Jeffrey Palmer

Quantitative Dose Optimization for Gene Therapy Trials: Implications for Project Optimus and Early‐Phase Design

Quantitative dose optimization in early phase clinical trials for investigational new drugs has been expanding across drug modalities and disease indications in response to the limitations of non‐quantitative or algorithmic methods of dose progression. In the context of the FDA's Project Optimus Initiative, which empha...